Search Results 1321-1330 of 17199 for monoclonal antibody

  1. ACP-196 in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies - Mayo Clinic

    Participation eligibility · Subjects who are hepatitis B core antibody (anti-HBc) positive and who are surface antigen negative will need to have a negative ...

  2. Pathology Research Core - Tissue Staining

    Routine IHC/IF. Automated immunostaining is performed using a variety of antibody detection chemistries, including diaminobenzidine (DAB) and alkaline ...

  3. Cancer - Diagnosis and treatment - Mayo Clinic

    Monoclonal antibody drugs · Mouth sores caused by cancer treatment: How to cope · No appetite? How to get nutrition during cancer treatment · Chemotherapy side ...

  4. Publications - Sebastian S. Lopez Chiriboga, M.D. - Mayo Clinic

    Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management. Front Neurol. 2022; ...

  5. Cyclophosphamide, Ixazomib, and Dexamethasone in Treating Patients With Previously Untreated Symptomatic Multiple Myeloma - Mayo Clinic

    Monoclonal gammopathy of undetermined significance (MGUS) or smoldering myeloma · Prior cytotoxic chemotherapy or corticosteroids for the treatment of multiple ...

  6. Muscle pain - Mayo Clinic

    Monoclonal antibody drugs · Mort Crim and Cancer · Mouth sores caused by cancer treatment: How to cope · Muscle cramp · Muscle strains · Myalgic ...

  7. Safety & Efficacy of Eculizumab to Prevent AMR in Living Donor Kidney Transplant Recipients Requiring Desensitization - Mayo Clinic

    About this study. The purpose of this trial is to determine the safety and efficacy of eculizumab in the prevention of antibody mediated rejection (AMR) in ...

  8. MDM2 Inhibitor AMG-232 and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma - Mayo Clinic

    Patients with known Positive Hepatitis B Surface Antigen (HepBsAg) (indicative of chronic Hepatitis B), positive Hepatitis total core antibody with negative ...

  9. A Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer - Mayo Clinic

    Prior anti-VEGF targeted monoclonal antibody therapies (e.g., bevacizumab and ramucirumab) are permitted. Treatment with any previous drug therapy within 2 ...

  10. A study of how current treatments impact the course of relapsed myeloma and the effect of the treatments on the quality-of-life measurements. - Mayo Clinic

    Relapsed MM refractory to at least one IMiD, PI, and anti-CD38 antibody ... Monoclonal protein, Skin changes (POEMS) syndrome. ... Prior or concomitant treatment ...